PT Tempo Scan Pacific Tbk

IDX:TSPC Stock Report

Market Cap: Rp11.0t

Tempo Scan Pacific Past Earnings Performance

Past criteria checks 2/6

Tempo Scan Pacific has been growing earnings at an average annual rate of 18%, while the Pharmaceuticals industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 5% per year. Tempo Scan Pacific's return on equity is 16.3%, and it has net margins of 9.7%.

Key information

18.0%

Earnings growth rate

17.9%

EPS growth rate

Pharmaceuticals Industry Growth20.4%
Revenue growth rate5.0%
Return on equity16.3%
Net Margin9.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Tempo Scan Pacific makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

IDX:TSPC Revenue, expenses and earnings (IDR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2413,503,6821,307,9593,309,0430
30 Jun 2413,410,1111,305,6423,295,5660
31 Mar 2413,327,8501,016,1033,437,3090
31 Dec 2313,119,7851,177,4323,417,7480
30 Sep 2312,930,9781,413,2113,519,9040
30 Jun 2312,799,6161,315,6093,577,1230
31 Mar 2312,515,6281,299,8733,529,5280
31 Dec 2212,254,3691,001,6283,454,0790
30 Sep 2211,979,281818,7013,096,1470
30 Jun 2211,690,793793,2493,039,1980
31 Mar 2211,463,255807,3652,970,7600
31 Dec 2111,234,443823,7682,892,4750
30 Sep 2111,221,801837,8142,819,3740
30 Jun 2111,098,709826,4102,794,6380
31 Mar 2110,946,622790,6362,675,3960
31 Dec 2010,968,402787,8032,772,8920
30 Sep 2010,913,436633,4382,982,5440
30 Jun 2010,988,140594,2863,154,6100
31 Mar 2011,054,774635,0333,357,7570
31 Dec 1910,993,842554,2633,384,6580
30 Sep 1910,838,260506,4983,382,4740
30 Jun 1910,645,094503,8503,321,8100
31 Mar 1910,409,876511,7853,235,3360
31 Dec 1810,088,119512,0293,173,6920
30 Sep 189,953,788524,5013,115,2880
30 Jun 189,771,237544,3223,080,2730
31 Mar 189,605,084539,9723,048,9250
31 Dec 179,565,462543,8043,015,0240
30 Sep 179,367,620518,9243,009,3410
30 Jun 179,048,306534,9182,846,2190
31 Mar 179,282,651537,9872,880,6530
31 Dec 169,138,239536,2742,810,0420
30 Sep 168,974,716461,1112,713,8110
30 Jun 168,863,164488,5362,670,1230
31 Mar 168,440,155495,7652,520,7660
31 Dec 158,181,482521,9592,436,5000
30 Sep 158,042,806551,8742,492,5780
30 Jun 157,897,221539,3322,464,0540
31 Mar 157,753,038559,4502,392,2040
31 Dec 147,512,115580,8702,279,8170
30 Sep 147,314,777608,4842,219,7970
30 Jun 147,145,508619,9722,117,3260
31 Mar 146,963,447652,4412,048,6610
31 Dec 136,854,889634,6232,049,1770

Quality Earnings: TSPC has high quality earnings.

Growing Profit Margin: TSPC's current net profit margins (9.7%) are lower than last year (10.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: TSPC's earnings have grown by 18% per year over the past 5 years.

Accelerating Growth: TSPC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: TSPC had negative earnings growth (-7.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (4%).

Return on Equity

High ROE: TSPC's Return on Equity (16.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Tempo Scan Pacific Tbk is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Helmy KristantoBNP Paribas Securities (Asia)
Selviana AripinHSBC
Harry SuPT Bahana Securities